Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Silver SCHEMBL17818670 | 0.93 | CA4 (0.33) | CA4 | |
| SCHEMBL17818654 | 0.71 | FFAR3 (0.36) | CA4 | |
| SCHEMBL5974938 | 0.67 | CA4 (0.33) | CA4 | |
| SCHEMBL7533994 | 0.67 | CA4 (0.39) | CA4 | |
| SCHEMBL25196181 | 0.65 | CA4 (0.57) | CA4 | |
| SCHEMBL17433623 | 0.65 | FFAR3 (0.36) | CA4 | |
| SCHEMBL17433672 | 0.65 | FFAR3 (0.36) | CA4 | |
| SCHEMBL21269349 | 0.65 | FFAR3 (0.36) | CA4 | |
| Lithium Ion SCHEMBL107373 | 0.65 | FFAR3 (0.36) | CA4 | |
| SCHEMBL21247500 | 0.65 | FFAR3 (0.36) | CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9683123-B2 | Silver ink | PESOLVE CO., LTD. (KR) | 2017-06-20 | — | — | US | disclosed |
| US-20160168408-A1 | SILVER INK | PESOLVE CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168408-A1 | SILVER INK | TP53, MKI67, NRAS | CA4 3179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.